natur
compound
becom
popular
treatment
ill
health
promot
mechan
action
safeti
profil
often
unknown
xyloket
b
xkb
novel
marin
compound
isol
mangrov
fungu
xylaria
sp
potent
antioxid
neuroprotect
cardioprotect
effect
howev
molecular
target
effect
drugmetabol
enzym
unknown
studi
aim
investig
potenti
molecular
target
xkb
use
bioinformat
approach
examin
effect
xkb
express
activ
rat
cytochrom
subfamili
member
use
midazolam
model
probe
ddicpi
server
predict
drugdrug
interact
via
chemicalprotein
interactom
employ
predict
target
xkb
databas
annot
visual
integr
discoveri
david
use
analyz
pathway
predict
target
xkb
homolog
model
perform
use
discoveri
studio
program
activ
express
rat
hepat
examin
rat
treat
xkb
mgkg
consecut
day
rat
plasma
concentr
midazolam
metabolit
determin
use
valid
highperform
liquid
chromatograph
method
bioinformat
analysi
show
function
protein
relat
signal
pathway
potenti
regul
xkb
molecular
dock
studi
show
xkb
bound
activ
site
human
cytochrom
rat
homolog
model
via
format
hydrogen
bond
vivo
studi
show
oral
administr
xkb
mgkg
rat
day
significantli
increas
area
plasma
concentrationtim
curv
auc
midazolam
concomit
decreas
plasma
clearanc
auc
ratio
midazolam
oral
administr
mgkg
xkb
day
markedli
reduc
activ
express
hepat
rat
taken
togeth
result
show
xkb
could
regul
network
molecular
protein
relat
signal
pathway
xkb
downregul
hepat
rat
xkb
might
caus
drug
interact
modul
activ
express
member
studi
warrant
confirm
mechan
action
xkb
investig
underli
mechan
regul
effect
xkb
subfamili
member
drug
design
develop
therapi
submit
manuscript
wwwdovepresscom
dovepress
dovepress
su
et
al
pharmacolog
activ
although
limit
spars
clinic
evid
applic
particular
lack
data
molecular
target
mechan
action
pharmacokinet
pk
mainli
focus
absorpt
distribut
metabol
excret
adm
toxicolog
natur
product
hand
mani
natur
product
abil
regul
import
drugmetabol
enzym
drug
transport
cytochrom
enzym
cyp
pglycoprotein
rais
safeti
concern
regard
use
natur
product
due
modulatori
effect
activ
express
drugmetabol
enzym
drug
transport
result
potenti
harm
drug
interact
eventu
advers
drug
reaction
human
cyp
superfamili
consist
function
gene
oxid
drug
clinic
use
human
subfamili
contain
four
member
abund
enzym
liver
intestin
importantli
predispos
induct
inhibit
expos
number
endogen
exogen
factor
probabl
result
alter
pk
profil
victim
drug
advers
drug
reaction
particular
drug
narrow
therapeut
index
digoxin
warfarin
carboplatin
rat
subfamili
contain
rat
ident
amino
acid
sequenc
human
share
lot
substrat
specif
inhibitor
select
cardiovascular
diseas
cvd
coronari
heart
diseas
stroke
lead
caus
death
throughout
world
million
peopl
die
cvd
account
global
death
million
death
result
coronari
heart
diseas
million
death
due
stroke
incid
cvd
increas
expos
individu
famili
societi
great
burden
pathogenesi
cvd
complic
oxid
stress
propos
causal
factor
pathogenesi
reduc
oxid
stress
report
promis
strategi
treatment
cvd
number
natur
product
show
potent
antioxid
effect
coadministr
natur
product
cardiovascular
drug
gain
increas
popular
effect
although
lack
systemat
preclin
clinic
data
pk
molecular
target
mechan
action
toxicolog
marin
organ
attract
sourc
drug
develop
numer
compound
isol
marin
organ
wide
rang
pharmacolog
activ
includ
antioxid
antiinflammatori
anticanc
effect
xyloket
b
xkb
figur
ketoconazol
midazolam
probucol
xyloket
b
follow
target
predict
databas
annot
visual
integr
discoveri
version
david
http
davidabccncifcrfgov
use
provid
biolog
function
interpret
potenti
target
xkb
deriv
ddicpi
protein
id
target
uniprotkb
nation
center
biotechnolog
inform
sourc
convert
gene
list
use
gene
id
convers
tool
david
david
add
biolog
function
annot
includ
gene
ontolog
pathway
proteinprotein
interact
function
group
gene
ie
cluster
diseas
associ
deriv
main
public
data
sourc
gene
interest
visual
use
biocarta
kyoto
encyclopedia
gene
genom
pathway
map
highest
classif
stringenc
select
function
annot
cluster
enrich
score
fisher
exact
test
pvalu
correspond
fals
discoveri
rate
calcul
identifi
functionalrel
gene
group
significantli
enrich
target
list
signific
enrich
gene
group
could
provid
clue
xkb
interact
molecular
target
systemat
way
drug
design
develop
therapi
submit
manuscript
wwwdovepresscom
dovepress
dovepress
su
et
al
probucol
duplic
chemic
structur
delet
ioniz
chang
tautom
isom
gener
lipinski
filter
threedimension
gener
set
true
ligand
prepar
xkb
midazolam
ketoconazol
probucol
dock
activ
site
human
rat
homolog
model
electrostat
energi
van
der
waal
forc
consid
dock
process
harmon
potenti
forc
constant
kcalmol
appli
outsid
grid
boundari
predict
adm
toxic
xkb
midazolam
ketoconazol
probucol
use
discoveri
studio
program
design
accelri
inc
adm
toxic
admet
profil
xkb
midazolam
ketoconazol
probucol
predict
briefli
chemic
structur
xkb
midazolam
ketoconazol
probucol
retriev
pubchem
databas
figur
structur
introduc
discoveri
studio
program
prepar
prepar
structur
duplic
chemic
structur
delet
ioniz
chang
tautom
isom
gener
lipinski
filter
threedimension
gener
set
true
follow
prepar
structur
xkb
midazolam
ketoconazol
probucol
subject
admet
evalu
use
admet
predictor
modul
paramet
includ
solubl
absorpt
permeabl
across
bloodbrain
barrier
interact
hepatotox
plasma
protein
bind
predict
four
differ
admet
absorpt
level
rang
indic
good
moder
low
low
absorpt
respect
admet
aqueou
solubl
level
classi
increas
preval
natur
product
includ
marin
product
use
improv
bodi
function
manag
variou
ailment
due
divers
novel
marin
compound
isol
mangrov
fungu
xylaria
sp
potent
antioxid
neuroprotect
cardioprotect
effect
found
xkb
relax
effect
blood
vessel
protect
endotheli
cell
oxid
injuri
induc
oxid
lowdens
lipoprotein
directli
scaveng
free
radicalgener
compound
protect
cell
oxygenglucos
depriv
injuri
strong
inhibitori
effect
lcalcium
channel
potent
antioxid
effect
xkb
suggest
promis
agent
treatment
oxid
stressassoci
condit
cvd
establish
doserespons
dosetox
relationship
xkb
investig
metabol
pk
rat
vivo
plasma
pk
xkb
follow
twocompart
model
distribut
phase
elimin
phase
xkb
show
short
elimin
halflif
minut
suggest
rapidli
distribut
bodi
also
rapidli
elimin
howev
molecular
target
respons
xkb
treatment
effect
xkb
regul
drugmetabol
enzym
unknown
present
studi
order
investig
molecular
target
xkb
predict
target
use
bioinformat
platform
analyz
interact
xkb
rat
use
homolog
model
follow
molecular
dock
examin
effect
oral
xkb
activ
express
hepat
rat
use
midazolam
model
substrat
interactom
xkb
predict
use
ddicpi
tool
webbas
server
predict
drugdrug
interact
via
chemicalprotein
interactom
protein
target
obtain
thirdparti
protein
structur
databas
name
pdbbind
total
protein
data
bank
pdb
entri
human
protein
avail
pdbbind
total
nonredund
pdb
correspond
ligand
bind
pocket
identifi
resolut
less
dock
box
pocket
defin
expand
circumscrib
cube
pocket
margin
six
direct
front
back
left
right
prepar
xkb
twodimension
structur
xkb
download
pubchem
hydrogen
gasteig
charg
ad
file
format
transform
use
vega
zz
dock
program
autodock
use
dock
xkb
molecul
pocket
gener
score
vector
dimens
zscore
calcul
use
methodolog
describ
elsewher
herein
empir
threshold
zscore
set
indic
bind
xkb
target
like
true
employ
discoveri
studio
program
design
accelri
inc
san
diego
ca
usa
dock
xkb
midazolam
ketoconazol
probucol
activ
site
human
rat
homolog
model
previous
describ
modif
due
lack
avail
crystal
structur
rat
hepat
built
homolog
model
base
report
human
crystal
structur
pdb
id
http
wwwrcsborgpdb
establish
homolog
model
rat
hepat
first
retriev
rat
sequenc
nation
center
biotechnolog
inform
ncbi
refer
sequenc
http
wwwncbinlmnihgov
protein
align
rat
sequenc
base
templat
human
follow
establish
homolog
model
human
rat
homolog
model
clean
modifi
prepar
prepar
xkb
midazolam
ketoconazol
anim
randomli
divid
five
group
treat
intraperiton
daili
salin
blank
control
soybean
oil
vehicl
ketoconazol
mgkg
posit
control
xkb
mgkg
consecut
day
anim
free
access
standard
laboratori
food
water
order
reduc
intestin
content
anim
fast
overnight
termin
studi
midazolam
mgkg
administ
oral
hour
last
dose
xkb
blood
sampl
collect
post
ocular
vein
minut
administr
midazolam
blood
sampl
immedi
centrifug
g
minut
obtain
plasma
store
analysi
anim
euthan
cervic
disloc
blood
collect
liver
sampl
collect
assess
activ
express
rat
liver
microsom
prepar
previous
describ
briefli
liver
tissu
collect
wash
icecold
kcl
buffer
ph
tissu
becam
pale
whitish
blot
dri
weigh
subsequ
step
perform
liver
sampl
homogen
three
volum
buffer
ph
use
tissu
homogen
liver
homogen
centrifug
g
minut
supernat
collect
centrifug
g
minut
supernat
thereaft
decant
microsom
pellet
resuspend
homogen
buffer
centrifug
g
minut
remov
hemoglobin
rat
liver
microsom
resuspend
sodium
phosphat
buffer
mm
ethylenediamin
tetraacet
acid
mm
dithiothreitol
glycerol
ph
store
analysi
protein
concentr
microsom
sampl
determin
use
bicinchonin
acid
protein
assay
pierc
chemic
rockford
il
usa
bovin
serum
albumin
standard
plasma
concentr
midazolam
metabolit
measur
hplc
previous
describ
slight
modif
hplc
method
valid
prior
determin
plasma
pk
midazolam
per
intern
confer
harmon
guidelin
valid
analyt
procedur
includ
specif
abil
unequivoc
determin
analyt
linear
respons
curv
analyt
lower
limit
quantif
concentr
analyt
signal
nois
ratio
precis
accuraci
result
repeat
recoveri
satisfactori
accuraci
precis
stabil
degrad
analyt
aliquot
plasma
dilut
naoh
diazepam
ad
intern
standard
mixtur
extract
ml
dichloromethan
pentan
ratio
vortex
second
upper
organ
phase
transfer
clean
glass
tube
residu
liquid
extract
upper
organ
phase
mixtur
evapor
dryness
dri
residu
dissolv
mobil
phase
centrifug
g
minut
supernat
subject
hplc
analysi
detect
use
ultraviolet
detector
nm
hplc
system
shimpack
mm
mm
revers
phase
column
pack
vpod
c
shimadzu
corpor
tokyo
japan
use
column
temperatur
set
mobil
phase
mm
ammonium
acet
buffer
ph
acetonitril
vv
flow
rate
ml
per
minut
sampl
analyz
within
valid
stabil
timefram
follow
determin
plasma
concentr
pk
paramet
midazolam
calcul
singlecompartment
analysi
use
pkslover
program
china
pharmaceut
univers
nanj
peopl
republ
china
freeli
avail
menudriven
addin
program
microsoft
excel
written
visual
basic
applic
pk
data
analysi
pk
paramet
calcul
absorpt
rate
constant
k
elimin
rate
constant
k
e
halflif
absorpt
halflif
elimin
volum
distribut
vf
bodi
clearanc
clf
maximum
plasma
concentr
observ
c
max
time
reach
c
max
max
area
plasma
concentrationtim
curv
auc
auc
area
first
moment
curv
aumc
mean
resid
time
calcul
use
formula
k
e
auc
calcul
use
trapezoid
rule
cl
calcul
formula
clf
doseauc
vf
follow
oral
administr
calcul
use
vf
clfk
e
equat
effect
xkb
rat
hepat
activ
examin
use
luminesc
assay
accord
manufactur
instruct
briefli
rat
liver
homogen
prepar
describ
previous
reaction
mixtur
ad
microtit
plate
contain
microsom
protein
luciferinipa
substrat
mm
potassium
phosphat
buffer
solut
ph
mix
gentli
plate
preincub
minut
reaction
initi
ad
nadph
mixtur
incub
minut
next
reconstitut
luciferin
detect
reagent
ad
well
reaction
mixtur
mix
plate
shaker
second
plate
incub
minut
activ
examin
luminesc
read
rel
activ
express
fold
chang
control
western
blot
use
investig
regul
effect
xkb
express
rat
liver
briefli
rat
liver
microsom
mg
denatur
minut
centrifug
g
minut
protein
sampl
resolv
sodium
dodecyl
sulfatepolyacrylamid
gel
transfer
onto
polyvinyliden
difluorid
membran
membran
block
one
hour
nonfat
milk
trisbuff
tween
buffer
follow
incub
overnight
respect
primari
antibodi
membran
wash
trisbuff
tween
buffer
incub
secondari
antibodi
one
hour
signal
detect
use
clariti
western
ecl
substrat
biorad
imag
system
quantif
perform
use
imagej
analyz
softwar
media
cybernet
bethesda
md
usa
rel
express
level
rat
liver
microsom
express
ratio
intens
blot
gapdh
data
express
mean
standard
deviat
pk
paramet
compar
use
oneway
analysi
varianc
follow
tukey
multipl
comparison
valu
consid
statist
signific
first
predict
molecular
target
xkb
use
webbas
ddicpi
tool
protein
possibl
interact
xkb
tabl
includ
involv
redox
homeostasi
eg
txn
xenobiot
metabol
eg
por
mtap
cell
prolifer
eg
apoptosi
eg
lipid
metabol
eg
ppara
ppard
signal
transduct
eg
rhoa
immun
inflammatori
respons
eg
lck
shown
tabl
david
analysi
identifi
function
cluster
significantli
enrich
enrich
score
target
list
deriv
molecular
dock
calcul
includ
energi
metabol
signal
transduct
vascular
regul
carbohydr
metabol
kyoto
encyclopedia
gene
genom
pathway
found
significantli
enrich
target
list
tabl
particular
pathway
metabol
xenobiot
cyp
enzym
predict
modul
xkb
david
analysi
addit
david
analysi
reveal
overlap
molecular
target
xkb
probucol
tabl
includ
pctp
cetp
prep
sord
cda
ctsb
probucol
antihyperlipidem
drug
origin
develop
treatment
coronari
arteri
diseas
withdrawn
us
market
target
share
xkb
probucol
suggest
xkb
may
promis
agent
lower
blood
lipid
given
predict
number
molecular
target
relat
signal
pathway
possibl
regul
xkb
perform
valid
studi
use
publish
data
extens
search
via
pubm
incept
august
four
publish
paper
report
molecular
target
mechan
action
xkb
xkb
reduc
oxid
stress
via
induct
heme
suppress
nadph
oxidas
activ
involv
signal
pathway
human
umbil
vein
endotheli
cell
consist
previou
studi
previou
studi
also
show
xkb
decreas
activ
nadph
oxidas
express
xkb
increas
express
human
umbil
vein
endotheli
cell
injuri
induc
oxid
lowdens
lipoprotein
xkb
decreas
mitochondri
superoxid
mitochondri
fragment
express
gtpase
dynaminrel
protein
mitochondri
membran
potenti
cell
data
provid
preliminari
evid
valid
predict
molecular
target
xkb
use
bioinformat
approach
follow
predict
valid
molecular
target
examin
possibl
interact
xkb
midazolam
probe
substrat
ketoconazol
inhibitor
probucol
antihyperlipidem
drug
human
rat
homolog
model
use
discoveri
studio
program
shown
tabl
tyrosin
kinas
play
essenti
role
select
matur
develop
tcell
thymu
matur
tcell
function
constitut
associ
cytoplasm
portion
surfac
receptor
play
key
role
tcrlink
signal
transduct
pathway
associ
tcr
peptid
antigenbound
mhc
complex
facilit
interact
mhc
class
ii
class
molecul
respect
therebi
recruit
associ
lck
vicin
complex
lck
phosphoryl
tyrosin
residu
within
immun
receptor
tyrosinebas
activ
motif
cytoplasm
tail
chain
subunit
initi
signal
pathway
addit
contribut
signal
receptor
molecul
associ
directli
cytoplasm
tail
upon
engag
molecul
lck
undergo
hyperphosphoryl
activ
also
play
role
receptorlink
signal
pathway
control
tcell
prolif
respons
bind
receptor
result
increas
activ
lck
express
stage
thymocyt
develop
requir
regul
matur
event
govern
pretcr
matur
fatti
acidbind
protein
brain
bfabp
could
involv
transport
far
unknown
hydrophob
ligand
potenti
morphogen
activ
develop
central
nervou
system
requir
establish
radial
glial
fiber
system
develop
brain
system
necessari
migrat
immatur
neuron
establish
cortic
layer
similar
thiol
proteas
cleav
asp
ala
releas
matur
cytokin
involv
varieti
inflammatori
process
import
defens
pathogen
cleav
activ
sterol
regulatori
elementbind
protein
also
promot
apoptosi
insulin
decreas
blood
glucos
concentr
increas
cell
permeabl
monosaccharid
amino
acid
fatti
acid
acceler
glycolysi
pentos
phosphat
cycl
glycogen
synthesi
liver
bind
polyubiquitin
monoubiquitin
regul
ligandinduc
degrad
endotheli
growth
factor
receptor
particip
clathrinmedi
endocytosi
may
involv
adult
synapt
function
plastic
brain
develop
serinethreonineprotein
kinas
gener
protein
kinas
capabl
phosphoryl
sever
known
protein
receptor
brainderiv
neurotroph
factor
nerv
growth
factor
involv
develop
andor
mainten
nervou
system
tyrosin
kinas
receptor
known
substrat
tyrosin
kinas
receptor
neutrophil
gelatinaseassoci
lipocalin
irontraffick
protein
involv
multipl
process
apoptosi
innat
immun
renal
develop
bind
iron
associ
acid
siderophor
share
structur
similar
bacteri
enterobactin
deliv
remov
iron
cell
depend
context
ironbound
form
intern
follow
bind
receptor
lead
releas
iron
subsequ
increas
intracellular
iron
concentr
contrast
associ
ironfre
form
receptor
follow
associ
intracellular
siderophor
iron
chelat
iron
transfer
extracellular
medium
therebi
reduc
intracellular
iron
concentr
involv
apoptosi
due
depriv
ironload
form
increas
intracellular
iron
concentr
without
promot
apoptosi
ironfre
form
decreas
intracellular
iron
level
induc
express
proapoptot
protein
result
apoptosi
involv
innat
immun
possibl
sequest
iron
lead
limit
bacteri
growth
enzym
appar
serv
quinon
reductas
connect
conjug
reaction
hydroquinon
involv
detoxif
pathway
well
biosynthet
process
vitamin
kdepend
glutam
residu
prothrombin
synthesi
ratelimit
enzym
de
novo
synthesi
guanin
nucleotid
therefor
involv
regul
cell
growth
may
also
role
develop
malign
growth
progress
tumor
corticosteroid
isozym
catalyz
revers
convers
cortisol
inact
metabolit
cortison
catalyz
revers
convers
intact
cell
reaction
run
one
direct
similar
degrad
neurotox
organophosph
ester
serum
proteas
play
import
role
activ
complement
system
via
mannosebind
lectin
activ
autocatalyt
cleavag
cleav
lead
activ
format
convertas
galectin
bind
lactos
relat
rang
sugar
may
involv
assembl
adheren
junction
cell
surfac
glycoprotein
receptor
involv
costimulatori
signal
essenti
tcrmediat
tcell
activ
act
posit
regul
tcell
coactiv
bind
least
ada
ptprc
bind
induc
tcell
prolifer
activ
tcell
manner
interact
ada
also
regul
lymphocyteepitheli
cell
adhes
associ
fap
involv
pericellular
proteolysi
extracellular
matrix
migrat
invas
endotheli
cell
extracellular
matrix
may
involv
promot
lymphat
endotheli
cell
adhes
migrat
tube
format
overexpress
enhanc
cell
prolifer
process
inhibit
act
also
serin
exopeptidas
dipeptidyl
peptidas
activ
regul
variou
physiolog
process
cleav
peptid
circul
includ
mani
chemokin
mitogen
growth
factor
neuropeptid
peptid
hormon
remov
ntermin
dipeptid
sequenti
polypeptid
unsubstitut
ntermini
provid
penultim
residu
prolin
requir
highaffin
bind
nerv
growth
factor
brainderiv
neurotroph
factor
known
substrat
tyrosin
kinas
receptor
crucial
role
develop
function
nocicept
recept
system
well
establish
thermal
regul
via
sweat
activ
either
signal
pathway
remov
aminotermin
methionin
nascent
protein
requir
normal
progress
cell
cycl
inhibit
synthesi
number
cytokin
includ
tnf
granulocytemacrophag
colonystimul
factor
produc
activ
macrophag
helper
tcell
fractalkin
solubl
form
chemotact
tcell
monocyt
neutrophil
membranebound
form
promot
adhes
leukocyt
endotheli
cell
may
play
role
regul
leukocyt
adhes
migrat
process
endothelium
bind
inhibitor
serin
proteas
primari
target
elastas
also
moder
affin
plasmin
thrombin
irrevers
inhibit
trypsin
chymotrypsin
plasminogen
activ
aberr
form
inhibit
insulininduc
nitric
oxid
synthesi
platelet
decreas
coagul
time
proteolyt
activ
insulin
plasmin
short
peptid
aat
revers
chymotrypsin
inhibitor
also
inhibit
elastas
trypsin
major
physiolog
function
protect
lower
respiratori
tract
proteolyt
destruct
human
leukocyt
elastas
show
greater
abil
mobil
cytoplasm
calcium
comparison
isoform
requir
brain
develop
matur
brain
function
import
role
regul
axon
growth
axon
guidanc
neurit
extens
block
axon
growth
attract
induc
phosphoryl
receptor
ddc
conjug
reduc
glutathion
wide
number
exogen
endogen
hydrophob
electrophil
catalyz
isomer
reaction
contribut
biosynthesi
steroid
hormon
effici
catalyz
obligatori
doublebond
isomer
precursor
testosteron
progesteron
respect
destroy
radic
normal
produc
within
cell
toxic
biolog
system
desatur
elong
fatti
acid
cholesterol
biosynthesi
drug
metabol
erythrocyt
methemoglobin
reduct
could
involv
cellcel
andor
cellmatrix
interact
necessari
normal
growth
control
proapoptot
protein
function
intracellularli
upstream
janu
kinas
activ
cytochrom
c
releas
conjug
reduc
glutathion
wide
number
exogen
endogen
hydrophob
electrophil
bind
activ
proteintyr
kinas
domain
act
adapt
mediat
associ
catalyt
unit
plasma
membran
necessari
insulinstimul
increas
glucos
uptak
glycogen
synthesi
insulinsensit
tissu
hepatocyt
growth
factor
hgf
hgf
potent
mitogen
matur
parenchym
hepatocyt
cell
seem
hepatotroph
factor
act
growth
factor
broad
spectrum
tissu
cell
type
detect
proteas
activ
receptor
hyaluron
acid
mediat
cellcel
cellmatrix
interact
affin
hyaluron
acid
possibl
also
affin
ligand
osteopontin
collagen
mmp
adhes
hyaluron
acid
play
import
role
cell
migrat
tumor
growth
progress
also
involv
lymphocyt
activ
recircul
home
hematopoiesi
alter
express
dysfunct
caus
numer
pathogen
phenotyp
great
protein
heterogen
due
numer
altern
splice
posttransl
modif
event
campspecif
phosphodiesteras
hydrolyz
second
messeng
camp
key
regul
mani
import
physiolog
process
may
involv
mediat
central
nervou
system
effect
therapeut
agent
rang
antidepress
antiasthmat
antiinflammatori
agent
campspecif
phosphodiesteras
hydrolyz
second
messeng
camp
key
regul
mani
import
physiolog
process
insert
membran
form
poorli
select
ion
channel
may
also
transport
chlorid
ion
channel
activ
depend
ph
membran
insert
seem
redoxregul
may
occur
oxid
condit
promot
cellsurfac
express
altern
cellular
function
like
potenti
role
angiogenesi
maintain
apicalbasolater
membran
polar
mitosi
cytokinesi
could
also
promot
endotheli
cell
prolifer
regul
endotheli
morphogenesi
tubulogenesi
rna
exonucleas
bind
histon
mrna
degrad
suggest
play
essenti
role
histon
mrna
decay
replic
group
last
nucleotid
histon
requir
effici
degrad
rna
substrat
also
abl
degrad
small
interf
rna
vitro
suggest
possibl
role
regul
rna
interfer
requir
bind
sequenc
present
stemloop
structur
abl
bind
mrna
requir
srrna
process
also
bind
ribosom
rna
bind
high
affin
stemloop
structur
replicationdepend
histon
premrna
enzym
appar
serv
quinon
reductas
connect
conjug
reaction
hydroquinon
involv
detoxif
pathway
well
biosynthet
process
vitamin
kdepend
glutam
residu
prothrombin
synthesi
tni
inhibitor
actomyosin
atpas
tnt
contain
bind
site
tropomyosin
tnc
bind
calcium
tnc
abolish
inhibitori
action
tn
actin
filament
inhibitor
serin
proteas
primari
target
elastas
also
moder
affin
plasmin
thrombin
irrevers
inhibit
trypsin
chymotrypsin
plasminogen
activ
aberr
form
inhibit
insulininduc
nitric
oxid
synthesi
platelet
decreas
coagul
time
proteolyt
activ
insulin
plasmin
short
peptid
aat
revers
chymotrypsin
inhibitor
also
inhibit
elastas
trypsin
major
physiolog
function
protect
lower
respiratori
tract
proteolyt
destruct
human
leukocyt
elastas
renin
highli
specif
endopeptidas
known
function
gener
angiotensin
angiotensinogen
plasma
initi
cascad
reaction
produc
elev
blood
pressur
increas
sodium
retent
kidney
work
concert
reductas
convert
steroid
hormon
catalyz
inactiv
potent
androgen
high
bilebind
abil
plasma
membraneassoci
small
gtpase
cycl
activ
gtpbound
inact
gdpbound
state
inact
state
bind
varieti
effector
protein
regul
cellular
respons
secretori
process
phagocytosi
apoptot
cell
epitheli
cell
polar
augment
product
reactiv
oxygen
speci
nadph
oxidas
initi
extrins
pathway
blood
coagul
serin
proteas
circul
blood
zymogen
form
factor
vii
convert
factor
viia
factor
xa
factor
xiia
factor
ixa
thrombin
minor
proteolysi
presenc
tissu
factor
calcium
ion
factor
viia
convert
factor
x
factor
xa
limit
proteolysi
factor
viia
also
convert
factor
ix
factor
ixa
presenc
tissu
factor
calcium
carboxypeptidas
convert
angiotensin
angiotensin
peptid
unknown
function
angiotensin
ii
angiotensin
vasodil
also
abl
hydrolyz
high
effici
may
import
regul
heart
function
case
human
coronaviru
sever
acut
respiratori
syndrom
infect
serv
function
receptor
spike
glycoprotein
coronavirus
enzym
cleav
lysarg
argser
bond
activ
reciproc
reaction
factor
xii
bind
neg
charg
surfac
also
releas
bradykinin
hmw
kininogen
may
also
play
role
reninangiotensin
system
convert
prorenin
renin
enzym
appar
serv
quinon
reductas
connect
conjug
reaction
hydroquinon
involv
detoxif
pathway
well
biosynthet
process
vitamin
kdepend
gammacarboxyl
glutam
residu
prothrombin
synthesi
catalyz
sulfat
conjug
mani
hormon
neurotransmitt
drug
xenobiot
compound
sulfon
increas
water
solubl
compound
therefor
renal
excret
also
result
bioactiv
form
activ
metabolit
sulfat
hydroxysteroid
like
dehydroepiandrosteron
isoform
preferenti
sulfon
cholesterol
isoform
avidli
sulfon
pregnenolon
cholesterol
remov
aminotermin
methionin
nascent
protein
catalyt
activ
human
toward
metval
peptid
consist
two
order
magnitud
higher
suggest
respons
process
protein
contain
ntermin
metval
metthr
sequenc
vivo
plasma
membraneassoci
small
gtpase
cycl
activ
gtpbound
inact
gdpbound
state
activ
state
bind
varieti
effector
protein
regul
cellular
respons
secretori
process
phagocytosi
apoptot
cell
epitheli
cell
polar
growthfactor
induc
format
membran
ruffl
isoform
b
acceler
gefindepend
gdpgtp
exchang
impair
gtp
hydrolysi
restor
partial
gtpaseactiv
protein
abl
bind
gtpasebind
domain
pak
fulllength
pak
gtpdepend
manner
suggest
insert
complet
abolish
effector
interact
nonreceptor
tyrosin
kinas
involv
variou
process
cell
cycl
progress
apoptosi
mitot
recombin
genet
instabl
histon
modif
cytoplasm
play
pivot
role
signal
transduct
via
associ
cytokin
receptor
constitut
initi
step
signal
mani
member
cytokin
receptor
superfamili
includ
receptor
growth
hormon
prolactin
leptin
erythropoietin
granulocytemacrophag
colonystimul
factor
thrombopoietin
multipl
il
follow
stimul
erythropoietin
erythropoiesi
autophosphoryl
activ
lead
associ
erythropoietin
receptor
tyrosin
phosphoryl
residu
epor
cytoplasm
domain
also
involv
promot
local
epor
plasma
membran
also
act
downstream
gprotein
coupl
receptor
play
role
control
bodi
weight
similar
nucleu
play
key
role
chromatin
specif
mediat
phosphoryl
histon
specif
tag
promot
exclus
chromatin
cooper
chaperon
heat
shock
protein
stabil
preexist
protein
aggreg
mediat
fold
newli
translat
polypeptid
cytosol
well
within
organel
chaperon
particip
process
abil
recogn
nonn
conform
protein
bind
extend
peptid
segment
net
hydrophob
charact
expos
polypeptid
translat
membran
transloc
follow
stressinduc
damag
case
rotaviru
infect
serv
postattach
receptor
viru
facilit
entri
cell
proteasomeassoci
deubiquitinas
releas
ubiquitin
proteasometarget
ubiquitin
protein
ensur
regener
ubiquitin
proteasom
revers
associ
subunit
proteasom
larg
fraction
proteasomefre
protein
exist
within
cell
requir
degrad
chemokin
receptor
critic
cell
chemotaxi
serv
also
physiolog
inhibitor
endoplasm
reticulumassoci
degrad
nonstress
condit
inhibit
degrad
unfold
endoplasm
reticulum
protein
via
interact
indispens
synapt
develop
function
neuromuscular
junction
phosphoryl
serinerich
argininerich
protein
spliceosom
complex
may
constitu
network
regulatori
mechan
enabl
sr
protein
control
rna
splice
phosphoryl
serin
threonin
tyrosin
similar
inhibitor
act
bait
tissu
plasminogen
activ
urokinas
protein
c
rapid
interact
tissu
plasminogen
activ
may
function
major
control
point
regul
fibrinolysi
known
pyridox
phosphatedepend
enzym
contain
heme
import
regul
hydrogen
sulfid
especi
brain
util
cystein
instead
serin
catalyz
format
hydrogen
sulfid
hydrogen
sulfid
gastrotransmitt
signal
cytoprotect
effect
act
neuromodul
brain
protect
neuron
hypox
injuri
similar
inhibitor
act
bait
tissu
plasminogen
activ
urokinas
protein
c
rapid
interact
tissu
plasminogen
activ
may
function
major
control
point
regul
fibrinolysi
epoxid
hydrolas
act
epoxid
alken
oxid
oxiran
aren
oxid
play
role
xenobiot
metabol
degrad
potenti
toxic
epoxid
also
determin
steadyst
level
physiolog
mediat
low
phosphatas
activ
map
kinaseactiv
protein
kinas
physiolog
substrat
seem
small
vitro
phosphoryl
glycogen
synthas
tyrosin
hydroxylas
kinas
phosphoryl
ser
peptid
sequenc
hydxrx
hyd
larg
hydrophob
residu
similar
mediat
erk
neutrophil
respons
particip
tnf
exocytosi
secretori
vesicl
neutrophil
play
role
phagocytosisinduc
respiratori
burst
activ
sex
hormonebind
globulin
shbg
function
androgen
transport
protein
may
also
involv
receptormedi
process
dimer
bind
one
molecul
steroid
specif
testosteron
regul
plasma
metabol
clearanc
rate
steroid
hormon
control
plasma
concentr
catalyz
convers
aldehyd
keton
alcohol
catalyz
reduct
prostaglandin
prostaglandin
phenanthrenequinon
oxid
prostaglandin
function
bidirect
hydroxysteroid
dehydrogenas
interconvert
activ
androgen
estrogen
progestin
cognat
inact
metabolit
preferenti
transform
rostenedion
testosteron
hydrolyz
itp
ditp
respect
monophosph
deriv
xanthosin
also
potenti
substrat
may
major
enzym
respons
regul
itp
concentr
cell
factor
ix
vitamin
kdepend
plasma
protein
particip
intrins
pathway
blood
coagul
convert
factor
x
activ
form
presenc
ca
ion
phospholipid
factor
viiia
cdocker
interact
energi
rang
kcalmol
xkb
midazolam
ketoconazol
probucol
xkb
form
hydrogen
bond
activ
site
human
pdb
id
figur
midazolam
ketoconazol
bound
activ
site
human
via
stack
figur
figur
respect
howev
probucol
show
hydrogen
bond
format
stack
charg
interact
human
figur
built
homolog
model
rat
base
crystal
structur
human
pdb
id
sequenc
similar
ident
human
rat
homolog
model
respect
cdocker
interact
energi
rang
kcalmol
tabl
dock
result
show
xkb
bound
activ
site
rat
homolog
model
hydrogen
bond
format
figur
midazolam
readili
dock
activ
site
rat
homolog
model
stack
figur
ketoconazol
bound
hydrogen
bond
format
activ
site
rat
homolog
model
figur
howev
hydrogen
bond
format
stack
charg
interact
probucol
rat
homolog
model
figur
compoundcyp
complex
highest
cdocker
interact
energi
select
twodimension
threedimension
imag
taken
figur
taken
togeth
result
show
xkb
could
bind
activ
site
human
rat
via
hydrogen
bond
format
andor
stack
xkb
may
serv
substrat
andor
inhibitor
two
enzym
predict
admet
properti
xkb
midazolam
ketoconazol
probucol
predict
admet
properti
xkb
midazolam
ketoconazol
probucol
shown
tabl
aqueou
solubl
valu
log
molar
solubl
xkb
xkb
show
moder
abil
penetr
bloodbrain
barrier
good
intestin
absorpt
profil
properti
optim
predict
space
compon
xkb
within
expect
rang
regard
ligand
hepatotox
plasma
protein
bind
level
midazolam
ketoconazol
show
similar
admet
profil
xkb
except
hepatotox
admet
predictor
show
optim
predict
space
valu
midazolam
optim
predict
space
valu
ketoconazol
rang
suggest
compound
might
hepatotox
tabl
probucol
low
aqueou
solubl
low
intestin
absorpt
agreement
data
report
drug
tabl
logp
valu
probucol
oral
bioavail
improv
use
nanotechnolog
valid
hplc
method
determin
midazolam
rat
plasma
valid
hplc
method
perform
prior
determin
plasma
pk
midazolam
rat
includ
examin
specif
linear
lower
limit
quantif
precis
accuraci
recoveri
stabil
figur
show
repres
chromatogram
blank
rat
plasma
rat
plasma
spike
midazolam
diazepam
result
indic
midazolam
diazepam
separ
complet
assay
condit
endogen
interf
peak
observ
retent
time
precis
accuraci
method
determin
use
qualiti
control
sampl
three
concentr
midazolam
precis
assay
express
rel
standard
deviat
mean
valu
nomin
concentr
accuraci
express
percentag
mean
valu
calcul
nomin
concentr
result
shown
tabl
valu
within
accept
rang
indic
develop
method
reproduc
accur
reliabl
quantit
determin
midazolam
rat
plasma
stabil
test
perform
low
medium
high
concentr
qualiti
control
sampl
result
shown
tabl
stock
solut
midazolam
stabl
least
day
store
concentr
midazolam
chang
significantli
exposur
sampl
room
temperatur
hour
three
freezethaw
cycl
result
indic
midazolam
stabl
enough
analyz
use
method
within
predetermin
timefram
given
observ
potenti
interact
xkb
rat
examin
effect
xkb
drug
metabol
success
oral
administr
xkb
schedul
use
midazolam
probe
drug
midazolam
wellknown
probe
substrat
human
unclear
appropri
probe
determin
rat
activ
vivo
major
metabolit
midazolam
human
mean
plasma
profil
midazolam
consecut
day
treatment
xkb
shown
group
figur
associ
pk
paramet
list
tabl
result
indic
signific
chang
pk
paramet
midazolam
rat
treat
xkb
day
comparison
vehicletr
rat
treatment
mgkg
xkb
increas
c
max
auc
auc
aumc
midazolam
respect
contrast
clf
vf
midazolam
decreas
rat
treat
mgkg
xkb
respect
compar
rat
receiv
vehicl
k
k
e
max
mean
resid
time
midazolam
remain
unchang
rat
given
mgkg
xkb
oral
day
data
also
show
oral
administr
xkb
mgkg
significantli
chang
auc
midazolam
oral
administr
xkb
mgkg
significantli
increas
auc
auc
aumc
respect
compar
control
rat
treat
vehicl
similarli
increas
auc
auc
aumc
respect
rat
treat
xkb
mgkg
day
compar
control
rat
compar
vehicletr
rat
ratio
plasma
auc
midazolam
significantli
decreas
rat
treat
oral
xkb
mgkg
howev
treatment
xkb
either
dose
chang
clf
vf
midazolam
rat
addit
compar
normal
salin
soybean
oil
singl
dose
ketoconazol
mgkg
significantli
increas
c
max
auc
auc
midazolam
respect
decreas
vf
clf
midazolam
respect
compar
vehicletr
rat
ratio
plasma
auc
midazolam
significantli
decreas
rat
treat
oral
ketoconazol
mgkg
collect
result
show
xkb
mgkg
significantli
reduc
metabol
midazolam
rat
without
mark
dose
depend
probabl
due
decreas
activ
sinc
total
clearanc
distribut
midazolam
metabolit
alter
xkb
possibl
modul
pathway
xkb
exclud
follow
observ
reduc
metabol
probe
substrat
hepat
activ
measur
use
luminesc
assay
rat
dose
xkb
day
shown
figur
activ
rat
hepat
significantli
inhibit
xkb
comparison
vehicl
group
soybean
oil
declin
activ
rat
treat
mgkg
xkb
respect
ketoconazol
also
show
significantli
inhibit
activ
reduct
compar
salinetr
group
examin
regulatori
effect
xkb
level
express
determin
western
blot
assay
shown
figur
administr
xkb
day
significantli
inhibit
express
rat
liver
compar
vehicl
group
soybean
oil
decreas
express
rat
treat
mgkg
xkb
respect
howev
administr
ketoconazol
chang
express
rat
liver
taken
togeth
xkb
potent
inhibitori
effect
express
activ
rat
liver
mechan
downregul
effect
xkb
hepat
rat
unknown
xkb
potent
antioxid
great
potenti
treatment
cvd
molecular
target
effect
drugmetabol
enzym
remain
unknown
human
major
cyp
subfamili
metabol
endogen
exogen
materi
modul
activ
express
would
caus
substanti
chang
drug
metabol
clinic
set
present
studi
predict
molecular
target
relat
signal
pathway
regul
xkb
found
xkb
interact
rat
hepat
homolog
model
via
hydrogen
bond
format
found
xkb
increas
auc
c
max
midazolam
inhibit
activ
express
level
rat
treat
xkb
day
find
indic
benefici
effect
xkb
attribut
regul
network
molecular
target
signal
pathway
xkb
regul
drug
metabol
suppress
activ
express
vivo
bioinformat
approach
becom
valuabl
way
predict
interactom
chemic
molecul
use
ddicpi
tool
predict
potenti
target
employ
david
analyz
molecular
target
relat
signal
pathway
regul
xkb
find
show
xkb
modul
number
function
protein
relat
signal
pathway
protein
signal
pathway
import
role
regul
redox
homeostasi
cell
prolifer
apoptosi
energi
metabol
metabol
xenobiot
lipid
carbohydr
metabol
inflammatori
respons
interestingli
xkb
share
number
molecular
target
probucol
initi
develop
antihyperlipidem
drug
treatment
coronari
arteri
diseas
remov
usa
market
found
prolong
qt
interv
overlap
molecular
target
suggest
xkb
regul
target
signal
pathway
probucol
probucol
report
lower
cholesterol
level
blood
increas
rate
lowdens
lipoprotein
catabol
inhibit
cholesterol
synthesi
delay
cholesterol
absorpt
also
potent
antioxid
suppress
oxid
cholesterol
lowdens
lipoprotein
cholesterol
efflux
regulatori
protein
consid
main
target
natur
marin
compound
xkb
may
promis
agent
treatment
cvd
potenti
cardiovascular
side
effect
minim
avoid
note
valu
shown
mean
standard
deviat
abbrevi
rsd
rel
standard
deviat
mdz
midazolam
ddicpi
approach
provid
rapid
inexpens
strategi
predict
potenti
target
identifi
drug
reposit
potenti
evalu
determin
advers
drug
reaction
chemicaldrug
via
molecular
dock
small
compound
across
human
proteom
although
webbas
program
sever
limit
may
affect
accuraci
outcom
exampl
ddicpi
abl
fulli
reveal
potenti
target
due
lack
human
protein
structur
assess
stringenc
xkb
shown
potent
antioxid
antiinflammatori
anticanc
effect
preclin
studi
support
predict
xkb
target
multipl
pathway
associ
oxid
stress
redox
homoeostasi
cell
prolifer
apoptosi
order
character
role
xkb
regul
cyp
next
perform
homolog
model
experi
examin
interact
xkb
rat
rat
homolog
model
built
base
human
pdb
id
data
show
rat
homolog
model
share
sequenc
similar
ident
human
report
rat
exhibit
homolog
amino
acid
sequenc
human
differ
may
affect
interact
xkb
rat
inde
find
show
xkb
interact
rat
homolog
model
via
hydrogen
bond
format
locat
activ
site
enzym
howev
interact
xkb
human
locat
activ
site
collect
model
studi
show
xkb
act
substrat
andor
inhibitor
rat
human
howev
extrapol
result
human
bear
mind
share
certain
degre
sequenc
similar
ident
function
valid
alway
need
admet
predictor
show
xkb
moder
water
solubl
oral
absorpt
probucol
low
water
solubl
oral
absorpt
consist
previous
report
data
predict
admet
profil
show
xkb
might
better
oral
agent
probucol
drug
develop
midazolam
probe
substrat
sed
amnes
anxiolyt
muscl
relax
anticonvuls
properti
human
wide
use
examin
degre
drug
interact
inhibitori
effect
xenobiot
activ
function
via
evalu
urinari
andor
plasma
level
midazolam
main
metabolit
studi
plasma
concentr
midazolam
determin
use
valid
hplc
method
high
specif
linear
precis
accuraci
recoveri
rate
midazolam
test
sampl
show
high
stabil
indic
hplc
method
reliabl
determin
plasma
concentr
midazolam
present
find
show
oral
administr
xkb
kgmg
day
significantli
elev
auc
c
max
midazolam
decreas
clf
xkb
also
show
inhibitori
effect
metabol
midazolam
similar
seen
ketoconazol
vivo
howev
remark
chang
k
k
e
vf
midazolam
rat
treat
xkb
collect
data
strongli
suggest
xkb
decreas
metabol
clearanc
midazolam
rat
notabl
report
midazolam
induc
effect
express
rat
hepatocyt
turn
may
affect
metabol
substrat
drug
found
oral
administr
xkb
day
significantli
reduc
express
activ
hepat
via
unknown
mechan
probabl
due
effect
oral
administr
xkb
hepat
activ
rat
liver
microsom
note
rat
treat
xkb
oral
mgkg
day
rat
sacrif
liver
collect
liver
microsom
prepar
activ
measur
use
luminesc
assay
bar
repres
mean
standard
deviat
ktz
posit
control
show
signific
inhibit
activ
compar
normal
salinetr
group
treatment
xkb
mgkg
decreas
activ
respect
oneway
analysi
varianc
abbrevi
cyp
cytochrom
xkb
xyloket
b
ktz
ketoconazol
toxicityassoci
target
eg
herg
potenti
interact
xkb
may
lead
unfavor
drug
interact
addit
short
elimin
halflif
xkb
may
neg
affect
concentr
site
action
compromis
therapeut
effect
clinic
practic
therefor
find
provid
clue
xkbbase
drug
develop
clinic
use
includ
structur
modif
nanotechnologybas
formul
minim
avoid
potenti
side
effect
prolong
elimin
halflif
achiev
therapeut
concentr
site
action
summari
found
medicin
effect
xkb
could
ascrib
modul
network
function
protein
relat
signal
pathway
xkb
significantli
inhibit
metabol
midazolam
rat
vivo
via
reduct
activ
express
hepat
find
suggest
xkb
may
behav
substrat
andor
inhibitor
probabl
alter
pk
profil
coadminist
drug
metabol
bodi
molecular
target
modul
effect
xkb
human
cyp
need
examin
function
valid
futur
